–
Inhibikase Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.8
FY22:
−18.1
FY23:
−20.1
FY24:
−28.6
FY25:
−52.0
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−28.6
FY25:
–
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−0.03
FY25:
−0.05
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.8
FY22:
−18.1
FY23:
−19.0
FY24:
−27.5
FY25:
−48.3
All amounts in millions USD